Understanding Drugs Markets
An Analysis of Medicines, Regulations and Pharmaceutical Systems in the Global South
Herausgeber: Baxerres, Carine; Cassier, Maurice
Understanding Drugs Markets
An Analysis of Medicines, Regulations and Pharmaceutical Systems in the Global South
Herausgeber: Baxerres, Carine; Cassier, Maurice
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Drawing on anthropology, historical sociology and social-epidemiology, this multidisciplinary book investigates how pharmaceuticals are produced, distributed, prescribed, (and) consumed, and regulated in order to construct a comprehensive understanding of the issues that drive (medicine) pharmaceutical markets in the Global South today.
Andere Kunden interessierten sich auch für
- Mickey C SmithGovernment, Big Pharma, and The People74,99 €
- Living Pharmaceutical Lives59,99 €
- Eve HannaGene and Cell Therapies154,99 €
- Teresa Ortiz-GómezGendered Drugs and Medicine72,99 €
- Ronald P EvensBiotechnology66,99 €
- Engineering Technologies and Clinical Translation164,99 €
- The Clinical Research Process in the Pharmaceutical Industry86,99 €
-
-
-
Drawing on anthropology, historical sociology and social-epidemiology, this multidisciplinary book investigates how pharmaceuticals are produced, distributed, prescribed, (and) consumed, and regulated in order to construct a comprehensive understanding of the issues that drive (medicine) pharmaceutical markets in the Global South today.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 296
- Erscheinungstermin: 31. Mai 2023
- Englisch
- Abmessung: 234mm x 156mm x 17mm
- Gewicht: 454g
- ISBN-13: 9781032043135
- ISBN-10: 103204313X
- Artikelnr.: 67825203
- Verlag: Taylor & Francis
- Seitenzahl: 296
- Erscheinungstermin: 31. Mai 2023
- Englisch
- Abmessung: 234mm x 156mm x 17mm
- Gewicht: 454g
- ISBN-13: 9781032043135
- ISBN-10: 103204313X
- Artikelnr.: 67825203
Carine Baxerres is researcher in anthropology at the French National Research Institute for Sustainable Development (IRD), in the research unit MERIT (IRD-University of Paris) and LPED (IRD-Aix-Marseille University). Her research interests are global and local pharmaceuticals markets in West Africa and more recently in South-east Asia, and health-seeking behaviors. ORCID No: 0000-0003-3023-3449 Maurice Cassier is currently a senior researcher at the French National Center for Scientific Research (CNRS, CERMES3, Paris). He has published extensively on the tensions between exclusive intellectual property rights on medicines and the right to health and has developed a research programme on the new geographies of the pharmaceutical industries in the Souths. He is currently working on new models of innovation and local production of health products, based on the categories of public goods and commons. ORCID No: 0000-0003-3908-8073
Introduction-Pharmaceutical markets in the Global South: shaped by history
and multiple regulations Part I. Varying choices for State regulation and
their consequences 1.Strengthening national pharmaceutical regulation
through local production 2.Strengths and weaknesses of State-controlled
wholesale distribution: Benin's CAME and wholesaler-distributors
3.Distribution and access to medicines: role of the pharmacist monopoly
4.From depharmaceuticalization to drug abundance: a social history of
pharmaceutic regulations in Cambodia Part II. Global and local markets of
new antimalarials 5.A new geography of pharmaceuticals: trajectories of
artemisinin-based medicines 6.Clashes between subsidized and private ACT
markets: when administrative, Global Health, and marketing regulations
collide 7.When the pharmaceutical system creates persistent attachments or
new appropriations of drug molecules: divergent ACT distribution and use in
Benin and Ghana 8.Standardized herbal medicines in Ghana: the construction
of a substantial share of the medicine market, especially for malaria Part
III. Pharmaceuticalization: medicines at the heart of health systems and
societies 9.Pharmaceutical representative activities in Benin and Ghana:
promoting firms while helping construct the pharmaceutical economy of
African countries 10.Self-medication versus consultation: individual
autonomy and dependence in health decisions 11.When subjective quality
shapes the whole economy of pharmaceutical distribution and production.
Conclusion-Rationalizing drug markets in the Global South: re-making
medicines essential
and multiple regulations Part I. Varying choices for State regulation and
their consequences 1.Strengthening national pharmaceutical regulation
through local production 2.Strengths and weaknesses of State-controlled
wholesale distribution: Benin's CAME and wholesaler-distributors
3.Distribution and access to medicines: role of the pharmacist monopoly
4.From depharmaceuticalization to drug abundance: a social history of
pharmaceutic regulations in Cambodia Part II. Global and local markets of
new antimalarials 5.A new geography of pharmaceuticals: trajectories of
artemisinin-based medicines 6.Clashes between subsidized and private ACT
markets: when administrative, Global Health, and marketing regulations
collide 7.When the pharmaceutical system creates persistent attachments or
new appropriations of drug molecules: divergent ACT distribution and use in
Benin and Ghana 8.Standardized herbal medicines in Ghana: the construction
of a substantial share of the medicine market, especially for malaria Part
III. Pharmaceuticalization: medicines at the heart of health systems and
societies 9.Pharmaceutical representative activities in Benin and Ghana:
promoting firms while helping construct the pharmaceutical economy of
African countries 10.Self-medication versus consultation: individual
autonomy and dependence in health decisions 11.When subjective quality
shapes the whole economy of pharmaceutical distribution and production.
Conclusion-Rationalizing drug markets in the Global South: re-making
medicines essential
Introduction-Pharmaceutical markets in the Global South: shaped by history
and multiple regulations Part I. Varying choices for State regulation and
their consequences 1.Strengthening national pharmaceutical regulation
through local production 2.Strengths and weaknesses of State-controlled
wholesale distribution: Benin's CAME and wholesaler-distributors
3.Distribution and access to medicines: role of the pharmacist monopoly
4.From depharmaceuticalization to drug abundance: a social history of
pharmaceutic regulations in Cambodia Part II. Global and local markets of
new antimalarials 5.A new geography of pharmaceuticals: trajectories of
artemisinin-based medicines 6.Clashes between subsidized and private ACT
markets: when administrative, Global Health, and marketing regulations
collide 7.When the pharmaceutical system creates persistent attachments or
new appropriations of drug molecules: divergent ACT distribution and use in
Benin and Ghana 8.Standardized herbal medicines in Ghana: the construction
of a substantial share of the medicine market, especially for malaria Part
III. Pharmaceuticalization: medicines at the heart of health systems and
societies 9.Pharmaceutical representative activities in Benin and Ghana:
promoting firms while helping construct the pharmaceutical economy of
African countries 10.Self-medication versus consultation: individual
autonomy and dependence in health decisions 11.When subjective quality
shapes the whole economy of pharmaceutical distribution and production.
Conclusion-Rationalizing drug markets in the Global South: re-making
medicines essential
and multiple regulations Part I. Varying choices for State regulation and
their consequences 1.Strengthening national pharmaceutical regulation
through local production 2.Strengths and weaknesses of State-controlled
wholesale distribution: Benin's CAME and wholesaler-distributors
3.Distribution and access to medicines: role of the pharmacist monopoly
4.From depharmaceuticalization to drug abundance: a social history of
pharmaceutic regulations in Cambodia Part II. Global and local markets of
new antimalarials 5.A new geography of pharmaceuticals: trajectories of
artemisinin-based medicines 6.Clashes between subsidized and private ACT
markets: when administrative, Global Health, and marketing regulations
collide 7.When the pharmaceutical system creates persistent attachments or
new appropriations of drug molecules: divergent ACT distribution and use in
Benin and Ghana 8.Standardized herbal medicines in Ghana: the construction
of a substantial share of the medicine market, especially for malaria Part
III. Pharmaceuticalization: medicines at the heart of health systems and
societies 9.Pharmaceutical representative activities in Benin and Ghana:
promoting firms while helping construct the pharmaceutical economy of
African countries 10.Self-medication versus consultation: individual
autonomy and dependence in health decisions 11.When subjective quality
shapes the whole economy of pharmaceutical distribution and production.
Conclusion-Rationalizing drug markets in the Global South: re-making
medicines essential